Combriax demonstrates strong immunogenicity across age groups, exceeding comparator vaccines for multiple influenza strains ...

Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, ...

The company said it would exit operations at some manufacturing plants in Germany and Singapore, and that as many as 1,860 ...

The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...

The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.

By Blake Brittain April 24 (Reuters) - German biotech company CureVac sued Moderna in Delaware federal court on Friday, ...

Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the vaccine offers strong protection — ramping up the ...

RNA rewards companies that can integrate biology, data science, manufacturing, and clinical development into a single ...

Moderna Inc. was hit with a new lawsuit alleging the vaccine maker’s Spikevax Covid-19 shots infringe 10 CureVac SE patents ...

COVID-19 has changed a lot over the years, as has our ability to protect ourselves through vaccines. And we recently got some new news on the virus. On March 19, the CDC released a report stating that ...

The company is making up for a decline in U.S. vaccine sales with better results elsewhere, continuing a turnaround that’s ...